Concepedia

Seema A. Bhat

SA

Statistics

Publications

28

Citations

2.1K

H-Index

19

Active since

2009

Affiliations

The Ohio State University(Current)

The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute

The Ohio State University Wexner Medical Center

University of Cincinnati

The University of Texas Southwestern Medical Center

Seema A. Bhat is an author at The Ohio State University specializing in medicine, pharmacology, and oncology.

ORCID

Publications per year

2009–2024

28

Publications

28

Risk of Malignant Progression in Barrett's Esophagus Patients: Results from a Large Population-Based Study

Seema A. Bhat, Helen G. Coleman, Foad Yousef et al. · JNCI Journal of the National Cancer Institute · 2011 · 742 citations · Full text

, , +17

Hypertension and incident cardiovascular events following ibrutinib initiation

Tyler Dickerson, Tracy Wiczer, Allyson Waller et al. · Blood · 2019 · 250 citations · Full text

, , +13

Resistance to Acalabrutinib in CLL Is Mediated Primarily By BTK Mutations

Jennifer A. Woyach, Ying Huang, Kerry A. Rogers et al. · Blood · 2019 · 107 citations

, , +14

Phase II Study of Combination Obinutuzumab, Ibrutinib, and Venetoclax in Treatment-Naïve and Relapsed or Refractory Chronic Lymphocytic Leukemia

Kerry A. Rogers, Ying Huang, Amy S. Ruppert et al. · Journal of Clinical Oncology · 2020 · 104 citations · Full text

, , +17

Acalabrutinib plus Obinutuzumab in Treatment-Naïve and Relapsed/Refractory Chronic Lymphocytic Leukemia

Jennifer A. Woyach, James S. Blachly, Kerry A. Rogers et al. · Cancer Discovery · 2020 · 79 citations · Full text

, , +14

1–5 of 28